首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >A Placebo-Controlled Pseudo-Randomized Crossover Trial of Botanical Agents for Gulf War Illness: Reishi Mushroom (Ganoderma lucidum) Stinging Nettle (Urtica dioica) and Epimedium (Epimedium sagittatum)
【2h】

A Placebo-Controlled Pseudo-Randomized Crossover Trial of Botanical Agents for Gulf War Illness: Reishi Mushroom (Ganoderma lucidum) Stinging Nettle (Urtica dioica) and Epimedium (Epimedium sagittatum)

机译:用于海湾战争疾病的安慰剂控制伪随机化植物药物的交叉试验:Reishi蘑菇(Ganoderma lucidum)刺痛荨麻(荨麻疹Dioica)和淫羊藿(eBimedium sargatum)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This report is third in a three-part clinical trial series screening potential treatments for Gulf War Illness (GWI). The goal of the project was to rapidly identify agents to prioritize for further efficacy research. We used a placebo-controlled, pseudo-randomized, crossover design to test the effects of reishi mushroom (Ganoderma lucidum), stinging nettle (Uritca dioica), and epimedium (Epimedium sagittatum) in 29 men with GWI. Participants completed 30 days of symptom reports for baseline, then a botanical line consisting of 30 days of placebo, followed by 30 days each of lower-dose and higher-dose botanical. After completing a botanical line, participants were randomized to complete the protocol with another botanical, until they completed three botanical trials. GWI symptom severity, pain, and fatigue were contrasted between the four conditions (baseline, placebo, lower-dose, higher dose) using linear mixed models. GWI symptom severity was unchanged from placebo in the reishi lower-dose condition (p = 0.603), and was higher in the higher-dose condition (p = 0.012). Symptom severity was not decreased from placebo with lower-dose stinging nettle (p = 0.604), but was significantly decreased with higher-dose stinging nettle (p = 0.048). Epimedium showed no significant decreases of GWI symptoms in the lower (p = 0.936) or higher (p = 0.183) dose conditions. Stinging nettle, especially at higher daily dosages, may help reduce the symptoms of GWI. Epimedium does not appear to beneficially affect GWI symptom severity, and reishi may exaggerate symptoms in some GWI sufferers. These results are in a small sample and are preliminary. Further research is required to determine if stinging nettle is indeed helpful for the treatment of GWI, and what dosage is optimal. This trial was registered on ClinicalTrials.gov ({"type":"clinical-trial","attrs":{"text":"NCT02909686","term_id":"NCT02909686"}}NCT02909686).
机译:本报告是三部分临床试验系列筛选海湾战争疾病(GWI)的临床试验潜在治疗。该项目的目标是迅速识别代理人以优先考虑进一步的疗效研究。我们使用了一个安慰剂控制的伪随机化的交叉设计,以测试Reishi蘑菇(灵芝),刺痛荨麻(Uritca dioica)和淫羊藿(淫羊藿)在29名男性中的影响。参与者完成了30天的基线症状报告,然后由安慰剂30天组成的植物线,其次是每次较低剂量和较高剂量的植物。在完成植物线后,参与者随机分配以与另一种植物学完成议定书,直到他们完成三种植物试验。 GWI症状严重程度,疼痛和疲劳在使用线性混合模型的四种条件(基线,安慰剂,低剂量,较高剂量)之间形成鲜明对比。 GWI症状严重程度从安慰剂较低剂量条件(P = 0.603)中不变,较高剂量条件较高(P = 0.012)。症状严重程度从安慰剂没有降低荨麻疹(P = 0.604),但用更高剂量的刺痛荨麻(P = 0.048)显着降低。淫羊藿表明,较低(P = 0.936)或更高(P = 0.183)剂量条件下没有显着降低的GWI症状。刺痛荨麻,特别是在每日剂量较高,可能有助于减少GWI的症状。淫羊藿没有有利地影响GWI症状严重程度,雷希米可能夸大一些GWI患者的症状。这些结果在一个小样本中并且是初步的。需要进一步的研究来确定刺痛的荨麻是否有助于治疗GWI,以及剂量是最佳的。该试验在Clinicaltrials.gov上注册({“类型”:“临床 - 试验”,“attrs”:{“text”:“nct02909686”,“term_id”:“nct02909686”}} NCT02909686)。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号